S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
NYSE:CNK

Cinemark Stock Forecast, Price & News

$20.21
-0.48 (-2.32 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$20.06
$20.74
50-Day Range
$13.94
$21.83
52-Week Range
$7.92
$27.84
Volume2.56 million shs
Average Volume4.10 million shs
Market Capitalization$2.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.57
30 days | 90 days | 365 days | Advanced Chart
Receive CNK News and Ratings via Email

Sign-up to receive the latest news and ratings for Cinemark and its competitors with MarketBeat's FREE daily newsletter.


Cinemark logo

About Cinemark

Cinemark Holdings, Inc. is a holding company, which engages in the provision of motion picture exhibition through its subsidiaries. It operates through the U.S. and International segments. The company was founded by Lee Roy Mitchell in 1984 and is headquartered in Plano, TX.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Motion picture theaters
Sub-Industry
Movies & Entertainment
CUSIP
17243V10
Employees
18,000
Year Founded
N/A

Sales & Book Value

Annual Sales
$686.31 million
Book Value
$6.76 per share

Profitability

Net Income
$-616.83 million
Net Margins
-135.90%

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$2.42 billion
Next Earnings Date
11/4/2021 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

1.83 out of 5 stars

Consumer Discretionary Sector

221st out of 385 stocks

Motion Picture Theaters Industry

2nd out of 4 stocks

Analyst Opinion: 2.2Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












Cinemark (NYSE:CNK) Frequently Asked Questions

Is Cinemark a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cinemark in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Cinemark stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CNK, but not buy additional shares or sell existing shares.
View analyst ratings for Cinemark
or view top-rated stocks.

What stocks does MarketBeat like better than Cinemark?

Wall Street analysts have given Cinemark a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cinemark wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Cinemark's next earnings date?

Cinemark is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Cinemark
.

How were Cinemark's earnings last quarter?

Cinemark Holdings, Inc. (NYSE:CNK) released its earnings results on Thursday, August, 5th. The company reported ($1.19) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($1.13) by $0.06. The company had revenue of $294.70 million for the quarter, compared to analyst estimates of $260.98 million. Cinemark had a negative net margin of 135.90% and a negative trailing twelve-month return on equity of 107.71%. The company's quarterly revenue was up 3174.4% compared to the same quarter last year. During the same period in the prior year, the business posted ($1.45) EPS.
View Cinemark's earnings history
.

How has Cinemark's stock price been impacted by Coronavirus?

Cinemark's stock was trading at $19.49 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CNK shares have increased by 3.7% and is now trading at $20.21.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for CNK?

8 Wall Street analysts have issued 12 month price targets for Cinemark's shares. Their forecasts range from $14.00 to $31.00. On average, they expect Cinemark's stock price to reach $24.00 in the next twelve months. This suggests a possible upside of 18.8% from the stock's current price.
View analysts' price targets for Cinemark
or view top-rated stocks among Wall Street analysts.

Who are Cinemark's key executives?

Cinemark's management team includes the following people:
  • Mark Zoradi, Chief Executive Officer & Director
  • Sean Gamble, President, Chief Operating & Financial Officer
  • Damian Wardle, Executive VP-Theatre & Technology Operations
  • Doug Fay, Senior Vice President-Information Technology
  • Michael D. Cavalier, Secretary, Executive VP & General Counsel

What is Mark Zoradi's approval rating as Cinemark's CEO?

295 employees have rated Cinemark CEO Mark Zoradi on Glassdoor.com. Mark Zoradi has an approval rating of 73% among Cinemark's employees.

Who are some of Cinemark's key competitors?

What other stocks do shareholders of Cinemark own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cinemark investors own include Pfizer (PFE), Carnival Co. & (CCL), AT&T (T), Wells Fargo & Company (WFC), AMC Entertainment (AMC), Southwest Airlines (LUV), Tesla (TSLA), Exxon Mobil (XOM), Delta Air Lines (DAL) and Intel (INTC).

What is Cinemark's stock symbol?

Cinemark trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNK."

Who are Cinemark's major shareholders?

Cinemark's stock is owned by many different retail and institutional investors. Top institutional shareholders include Hodges Capital Management Inc. (0.67%), State of Alaska Department of Revenue (0.06%), Louisiana State Employees Retirement System (0.04%), Oregon Public Employees Retirement Fund (0.04%), First Dallas Securities Inc. (0.02%) and Nisa Investment Advisors LLC (0.01%). Company insiders that own Cinemark stock include Lee Roy Mitchell, Mark Zoradi, Michael Cavalier, Valmir Fernandes and Ximena G Humrichouse.
View institutional ownership trends for Cinemark
.

Which major investors are selling Cinemark stock?

CNK stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC. Company insiders that have sold Cinemark company stock in the last year include Michael Cavalier, and Valmir Fernandes.
View insider buying and selling activity for Cinemark
or view top insider-selling stocks.

Which major investors are buying Cinemark stock?

CNK stock was bought by a variety of institutional investors in the last quarter, including Hodges Capital Management Inc., State of Alaska Department of Revenue, Louisiana State Employees Retirement System, Oregon Public Employees Retirement Fund, and First Dallas Securities Inc.. Company insiders that have bought Cinemark stock in the last two years include Lee Roy Mitchell, Mark Zoradi, and Ximena G Humrichouse.
View insider buying and selling activity for Cinemark
or or view top insider-buying stocks.

How do I buy shares of Cinemark?

Shares of CNK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cinemark's stock price today?

One share of CNK stock can currently be purchased for approximately $20.21.

How much money does Cinemark make?

Cinemark has a market capitalization of $2.42 billion and generates $686.31 million in revenue each year. The company earns $-616.83 million in net income (profit) each year or ($5.25) on an earnings per share basis.

How many employees does Cinemark have?

Cinemark employs 18,000 workers across the globe.

What is Cinemark's official website?

The official website for Cinemark is www.cinemark.com.

Where are Cinemark's headquarters?

Cinemark is headquartered at 3900 DALLAS PARKWAY, PLANO TX, 75093.

How can I contact Cinemark?

Cinemark's mailing address is 3900 DALLAS PARKWAY, PLANO TX, 75093. The company can be reached via phone at (972) 246-3627 or via email at [email protected].


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.